Einstein, Mark H <br/><br/>
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.  [electronic resource] 

 -  Human vaccines  Oct 2009 
 - 705-19 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1554-8619 
<br/><br/><label>Standard No.: </label>10.4161/hv.5.10.9518  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Neutralizing--blood<br/>Antibodies, Viral--blood<br/>Cancer Vaccines--adverse effects<br/>Female<br/>Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18<br/>Humans<br/>Middle Aged<br/>Neutralization Tests<br/>Papillomaviridae--isolation & purification<br/>Papillomavirus Infections--prevention & control<br/>Papillomavirus Vaccines--adverse effects<br/>Young Adult